The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients
- 5 November 2007
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 199 (1) , 147-153
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- HIV-infected patients with lipodystrophy have higher rates of carotid atherosclerosis: The role of monocyte chemoattractant protein-1Cytokine, 2006
- Functional and Structural Markers of Atherosclerosis in Human Immunodeficiency Virus-Infected PatientsJACC, 2006
- Lipids, metabolic syndrome, and risk factors for future cardiovascular disease among HIV-infected patientsCurrent HIV/AIDS Reports, 2005
- Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected AdultsNew England Journal of Medicine, 2005
- Metabolic Syndrome Among HIV-Infected PatientsDiabetes Care, 2005
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation, 2002
- High-density lipoprotein cholesterol is low in HIV-infected patients with lipodystrophic fat expansions: implications for pathogenesis of fat redistributionAIDS, 2002
- Low lipolytic enzyme activity in patients with severe hypertriglyceridemia on highly active antiretroviral therapyAIDS, 2001
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Mechanism of fluorescent fatty acid transfer from adipocyte fatty acid binding protein to membranesBiochemistry, 1993